Betulinic acid-doxorubicin drug combination synergistically supresses cell viability and enhances apoptotic death in acute myeloid leukaemia cell lines by increasing Bax/Bcl-2 ratio
Conference poster
Vu, M., Kassouf, N., Bell, C. and Appiah, S. 2018. Betulinic acid-doxorubicin drug combination synergistically supresses cell viability and enhances apoptotic death in acute myeloid leukaemia cell lines by increasing Bax/Bcl-2 ratio. NCRI Cancer Conference (2018). Glasgow, Scotland 04 - 06 Nov 2018
Type | Conference poster |
---|---|
Title | Betulinic acid-doxorubicin drug combination synergistically supresses cell viability and enhances apoptotic death in acute myeloid leukaemia cell lines by increasing Bax/Bcl-2 ratio |
Authors | Vu, M., Kassouf, N., Bell, C. and Appiah, S. |
Abstract | Background |
Research Group | Biomarkers for Cancer group |
Conference | NCRI Cancer Conference (2018) |
Publication dates | |
06 Nov 2018 | |
Publication process dates | |
Deposited | 29 Jan 2019 |
Completed | 06 Nov 2018 |
Accepted | 01 Sep 2018 |
Output status | Published |
Language | English |
https://repository.mdx.ac.uk/item/88267
Restricted files
Publisher's version
98
total views0
total downloads2
views this month0
downloads this month